Compare WVE & KN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WVE | KN |
|---|---|---|
| Founded | 2012 | 1946 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Consumer Electronics/Appliances |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.0B |
| IPO Year | 2015 | 2013 |
| Metric | WVE | KN |
|---|---|---|
| Price | $13.25 | $25.09 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 15 | 3 |
| Target Price | ★ $30.87 | $22.33 |
| AVG Volume (30 Days) | ★ 2.2M | 629.0K |
| Earning Date | 05-29-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 118.94 |
| EPS | N/A | ★ 0.50 |
| Revenue | $3,704,000.00 | ★ $593,200,000.00 |
| Revenue This Year | N/A | $9.40 |
| Revenue Next Year | $119.93 | $6.98 |
| P/E Ratio | ★ N/A | $49.64 |
| Revenue Growth | ★ 149.43 | 7.17 |
| 52 Week Low | $5.28 | $12.19 |
| 52 Week High | $21.73 | $28.74 |
| Indicator | WVE | KN |
|---|---|---|
| Relative Strength Index (RSI) | 47.06 | 41.88 |
| Support Level | $12.53 | $23.81 |
| Resistance Level | $14.56 | $25.33 |
| Average True Range (ATR) | 0.79 | 0.85 |
| MACD | -0.04 | -0.43 |
| Stochastic Oscillator | 26.10 | 24.85 |
WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.
Knowles Corp is engaged in the manufacturing of micro-acoustic microphones and balanced armature speakers, audio solutions, high-performance capacitors, and radio frequency filtering products. It operates in two segments; the Precision Devices segment specializes in the design and delivery of high-performance capacitor products and RF solutions; and Medtech & Specialty Audio segment designs and manufactures microphones and balanced armature speakers used in applications. The majority of its revenue comes from the Precision Devices. Geographically, it operates in United States, Asia, Other Americas, Europe and Others, out of which United States generates maximum revenue.